Published 21:40 IST, November 24th 2020

Pfizer, Moderna, Oxford, Sputnik V: As Covid Vaccines publish results, here's what we know

Phase 3 clinical trial data for 4 Covid vaccine candidates has been released in the past few weeks. Here's an analysis of Pfizer, Moderna, Oxford & Sputnik V

Reported by: Ankit Prasad
Follow: Google News Icon
  • share
null | Image: self
Advertisement

About one year on from what Chinese media records as first case of COVID-19, it appears that a vaccine that may offer a tangible 'rmalcy-restoring' intervention may be within touching distance. In fact, re may be a few such rays of light on hand, which give rise to a flurry of questions that will undoubtedly need answering. But first, here's a downlo of four of vaccine candidates that have recently published results from ir phase 3 clinical trials:

Pfizer, Moderna, Oxford, Sputnik V: A comparison of Covid vaccines' phase 3 trial efficacy & stor factors

1. Pfizer's Vaccine (also BioNTech, Fosun Pharma) - 

Pfizer's vaccine has been demonstrated to be 95% effective against Covid 28 days after first dose (i.e. 7 days after second dose)

Advertisement

i.e. Dose 1 + 21 days + Dose 2 + 7 days -> 95% efficacy

results were published after conclusion of phase 3 study which enrolled 43,661 participants. It found 170 confirmed cases of COVID-19, with 162 observed in placebo group (those who didn't get vaccine) versus 8 in vaccine group.

Advertisement

Pfizer's stor plan is that it has 'developed specially designed, temperature-controlled rmal shippers utilizing dry ice to maintain temperature conditions of -70°C±10°C. y can be used be as temporary stor units for 15 days by refilling with dry ice.' Essentially, however, vaccine in its current form needs to be stored at -70°C.

RE: Pfizer's press release/strong>

Advertisement

2.  Moderna's Vaccine: (mRNA-1273)

Moderna's vaccine has shown an efficacy of 94.5% two weeks after second dose in an interim analysis

i.e. Dose 1 + 21 days + Dose 2 + 14 days -> 94.5%

study enrolled more than 30,000 people, in which 90 cases of Covid were observed in placebo group versus 5 cases in vaccine group.

Moderna plans to submit an emergency use authorisation application based on a final study of 151 cases, results of which are expected.

Moderna says stor and handling of vaccine can be done using existing infrastructure. vaccine is survivable in a standard medical refrigerator at 2-8 degree Celsius for up to 30 days and longer in a freezer (-4 to -20 degree Celsius) 

RE: Moderna's press release

3.Oxford vaccine (University of Oxford, Astrazeneca, Serum Institute):

Interim phase 3 data analysing 131 COVID cases presented two key findings:

first was that a half dose and n a full dose is 90% effective

i.e. Half Dose 1 + 21 days + Dose 2 + unspecified number of days -> 90% efficacy

second was that a full dose and n ar full dose is 62% effective

i.e. Dose 1 + 21 days + Dose 2 + unspecified number of days -> 62% efficacy

Combining data from two dosing regimens, efficacy was found to be 70.4%.

Oxford says, "Crucially, vaccine can be easily ministered in existing healthcare systems, stored at ‘fridge temperature’ (2-8 °C) and distributed using existing logistics."

RE: Oxford's press release

4. Russian vaccine Sputnik V:

A second interim analysis of phase 3 trial data analyses 39 confirmed cases  (31 from placebo group, 8 from vaccine group) in a study comprising 18,794 volunteers. It presents two results for same regimen:

On day 28 after first dose, a 91.4% efficacy was reported

i.e. Dose 1 + 21 days + Dose 2 + 7 days -> 91.4% efficacy

On day 42 after first dose, a 95% efficacy was reported

i.e. Dose 1 + 21 days + Dose 2 + 21 days -> 95% efficacy    

vaccine's vials must be stored at -18 degree Celsius or below, though a freeze-dried version is being tested that may be stored in a regular fridge (2-8 degree Celsius).

RE: Sputnik V press release

re are numerous or Covid vaccines in works, including from India and China, and y are unlikely to want to wait too long to publish ir own clinical trial data, interim or final. As per Worldometer, at time of publishing, almost 60 million Coronavirus cases have been reported worldwide with over 1.4 million people succumbing. re are an estimated 17 million active infections. vaccination of world's population is likely to be single-largest collective undertaking in history of humanity.

21:20 IST, November 24th 2020